Immunizing Newborns Against the VRS Could Avoid 61% of Income in Their First Two Months

noticiasdealava.eus

Noticias de Navarra

View article

Deia

View article

noticiasdegipuzkoa.eus

View article

+3 Reposted by 3 other sources

Factuality

Ownership

Immunization of newborns against the syncytial respiratory virus (SVR) could prevent 61% of hospitalizations associated with this infection during the first two months of life, according to a report published on Wednesday by the European Center for Disease Prevention and Control (ECDC). The estimate is based on a scenario in which 90% of babies receive long-acting monoclonal antibodies at birth.

diarioestrategia.cl

Factuality

Ownership

A new report by the European Centre for Disease Prevention and Control (ECDC) indicates that universal vaccination of newborns against the syncytial respiratory virus (VRS) could substantially reduce disease-related hospitalizations of infants during the winter season.

news4health.gr

Factuality

Ownership

A new report from the European Centre for Disease Prevention and Control shows that administering long-acting monoclonal antibodies to newborns could prevent 61% of RSV hospitalisations in the first two months of life. Vaccination of pregnant women also offers significant protection. A significant reduction in infant hospitalisations due to respiratory syncytial virus (RSV) could be achieved through universal immunisation of newborns, according …

quotidianosanita.it

Factuality

Ownership

A multi-model Ecdc study compares long-term monoclonal antibodies and maternal vaccine. With high coverage, the first avoid 61% of hospitalizations in the first two months of life, compared to 52% of the vaccine. National decision makers will now have to assess costs. STUDIO The post Rsv. Monoclonal antibodies on newborns reduce hospitalizations by 61%. But the cost node appeared first on Quotidiano Sanità remains.